NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/02/2026
Voltar para busca
Dado oficial do USPTO
INFLEXIONRX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
20/02/2026
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
15/03/2021
Data de registro
18/06/2024
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/06/2024
Última transação
20/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
GADSON, SHARI B.
Unidade examinadora
N20
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Prescient Healthcare Group Limited
Representantes
Patrick C. Stephenson Kutak Rock LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
downloadable software for receivingreviewingorganizingstoringsharingdownloading and editing competitive informationintelligenceinsightsnewsregulatory informationscientific informationclinical datamarket data and social media data relating to the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries; downloadable software for use in receiving consulting and advisory services and collaborating with consultantsadvisors and internal resources in the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries
Classe 42
Providing on-line non-downloadable software for receivingreviewingorganizingstoringsharingdownloading and editing competitive informationintelligenceinsightsnewsregulatory informationscientific informationclinical datamarket data and social media data relating to the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries; providing on-line non-downloadable software for use in receiving consulting and advisory services and collaborating with consultantsadvisors and internal resources in the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/02/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/12/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/11/2024
FIMP
FINAL DISPOSITION PROCESSED
22/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
18/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
08/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
28/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
28/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/11/2023
GNRT
NON-FINAL ACTION E-MAILED
02/11/2023
CNRT
NON-FINAL ACTION WRITTEN
02/11/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
31/08/2023
DOCK
ASSIGNED TO EXAMINER
28/08/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
26/08/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/03/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/02/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/06/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/06/2022
CNSL
SUSPENSION LETTER WRITTEN
08/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/05/2022
RFNT
REFUSAL PROCESSED BY IB
07/12/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/11/2021
RFRR
REFUSAL PROCESSED BY MPU
15/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
23/10/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/10/2021
CNRT
NON-FINAL ACTION WRITTEN
20/10/2021
DOCK
ASSIGNED TO EXAMINER
19/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INFLEXIONRX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.